Basic Information
| RNALocate ID: | RLID:11000864 |
| RNA Symbol: | hsa-miR-26b-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-26b |
| RNA ID: | miRBase:MIMAT0000083 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21670082 |
| Tissue/Cell Line: | Renal cancer cells |
| Method: | qRT-PCR|TaqMan miRNA assay |
| Condition: | Human CD105+ and CD105- renal carcinomas cells |
| Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001357 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001358 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001359 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001360 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11000861 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000862 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000863 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000865 | Exosome | Breast milk | 22211110 |
| RLID:11000866 | Exosome | Brain tissue | 23382797 |
| RLID:11000867 | Exosome | Plasma | 23663360 |
| RLID:11000868 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000869 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000870 | Microvesicle | Plasma | 23077538 |
| RLID:11000871 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000019 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000282 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-26b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-33339 |
| MNDR | hsa-miR-26b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-33340 |
| MNDR | hsa-miR-26b-5p | Oral squamous cell carcinoma | MNDR-E-MI-33341 |
| MNDR | hsa-miR-26b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-33342 |
| MNDR | hsa-miR-26b-5p | Medulloblastoma | MNDR-E-MI-33343 |
| MNDR | hsa-miR-26b-5p | B cell lymphoma of malt type | MNDR-E-MI-33344 |
| MNDR | hsa-miR-26b-5p | Ovarian clear cell carcinoma | MNDR-E-MI-33345 |
| MNDR | hsa-miR-26b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-33346 |
| MNDR | hsa-miR-26b-5p | Lymphoma | MNDR-E-MI-33347 |
| MNDR | hsa-miR-26b-5p | Lymphoma non-hodgkin | MNDR-E-MI-33348 |
| MNDR | hsa-miR-26b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-33349 |
| MNDR | hsa-miR-26b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-33350 |
| MNDR | hsa-miR-26b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-33351 |
| MNDR | hsa-miR-26b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-33352 |
| MNDR | hsa-miR-26b-5p | Breast cancer luminal | MNDR-E-MI-33353 |
| MNDR | hsa-miR-26b-5p | Niemann-pick disease type c | MNDR-E-MI-33354 |
| MNDR | hsa-miR-26b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-33355 |
| MNDR | hsa-miR-26b-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-33356 |
| MNDR | hsa-miR-26b-5p | Dermatomyositis | MNDR-E-MI-33357 |
| MNDR | hsa-miR-26b-5p | Prostate cancer | MNDR-E-MI-33358 |
| MNDR | hsa-miR-26b-5p | Gastric cancer | MNDR-E-MI-33359 |
| MNDR | hsa-miR-26b-5p | Gastric lymphoma | MNDR-E-MI-33360 |
| MNDR | hsa-miR-26b-5p | Alzheimer disease | MNDR-E-MI-33361 |
| MNDR | hsa-miR-26b-5p | Intracranial aneurysm | MNDR-E-MI-33362 |
| MNDR | hsa-miR-26b-5p | Urinary bladder cancer | MNDR-E-MI-33363 |
| MNDR | hsa-miR-26b-5p | Esophageal carcinoma | MNDR-E-MI-33364 |
| MNDR | hsa-miR-26b-5p | Dysautonomia familial | MNDR-E-MI-33365 |
| MNDR | hsa-miR-26b-5p | Head and neck cancer | MNDR-E-MI-33366 |
| MNDR | hsa-miR-26b-5p | Lewy body dementia | MNDR-E-MI-33367 |
| MNDR | hsa-miR-26b-5p | Leukemia | MNDR-E-MI-33368 |
| MNDR | hsa-miR-26b-5p | Cardiovascular disease | MNDR-E-MI-33369 |
| MNDR | hsa-miR-26b-5p | Lung cancer | MNDR-E-MI-33370 |
| MNDR | hsa-miR-26b-5p | Parkinson disease | MNDR-E-MI-33371 |
| MNDR | hsa-miR-26b-5p | Niemann-pick disease | MNDR-E-MI-33372 |
| MNDR | hsa-miR-26b-5p | Breast cancer | MNDR-E-MI-33373 |
| MNDR | hsa-miR-26b-5p | Pituitary neoplasms | MNDR-E-MI-33374 |
| MNDR | hsa-miR-26b-5p | Pancreatic cancer | MNDR-E-MI-33375 |
| MNDR | hsa-miR-26b-5p | Melanoma | MNDR-E-MI-33376 |
| MNDR | hsa-miR-26b-5p | Rectum adenocarcinoma | MNDR-E-MI-33377 |
| MNDR | hsa-miR-26b-5p | Nephroblastoma | MNDR-E-MI-33378 |
| MNDR | hsa-miR-26b-5p | Colon cancer | MNDR-E-MI-33379 |
| MNDR | hsa-miR-26b-5p | Colon adenocarcinoma | MNDR-E-MI-33380 |
| MNDR | hsa-miR-26b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-33381 |
| MNDR | hsa-miR-26b-5p | Ovarian cancer | MNDR-E-MI-33382 |
| MNDR | hsa-miR-26b-5p | Prostate adenocarcinoma | MNDR-E-MI-33383 |
| MNDR | hsa-miR-26b-5p | Laryngeal carcinoma | MNDR-E-MI-33384 |
| MNDR | hsa-miR-26b-5p | Kidney cancer | MNDR-E-MI-33385 |
| MNDR | hsa-miR-26b-5p | Glioblastoma | MNDR-E-MI-33386 |
| MNDR | hsa-miR-26b-5p | Glioma | MNDR-E-MI-33387 |
| MNDR | hsa-miR-26b-5p | Oligodendroglioma | MNDR-E-MI-33388 |
| MNDR | hsa-miR-26b-5p | Central nervous system lymphoma | MNDR-E-MI-33389 |
| MNDR | hsa-miR-26b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-33390 |
| MNDR | hsa-miR-26b-5p | Epilepsy temporal lobe | MNDR-E-MI-33391 |
| MNDR | hsa-miR-26b-5p | Osteosarcoma | MNDR-E-MI-33392 |
| MNDR | hsa-miR-26b-5p | Inclusion body myositis | MNDR-E-MI-33393 |
| MNDR | hsa-miR-26b-5p | Meningioma | MNDR-E-MI-33394 |
| MNDR | hsa-miR-26b-5p | Liver cancer | MNDR-E-MI-33395 |
| MNDR | hsa-miR-26b-5p | Cervical adenocarcinoma | MNDR-E-MI-33396 |
| MNDR | hsa-miR-26b-5p | Gastric adenocarcinoma | MNDR-E-MI-33397 |
| MNDR | hsa-miR-26b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-33398 |
| MNDR | hsa-miR-26b-5p | Pituitary adenoma | MNDR-E-MI-33399 |
| MNDR | hsa-miR-26b-5p | Lung squamous cell carcinoma | MNDR-E-MI-33400 |
| MNDR | hsa-miR-26b-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-33401 |
| MNDR | hsa-miR-26b-5p | Lung adenocarcinoma | MNDR-E-MI-33402 |
| MNDR | hsa-miR-26b-5p | Thyroid carcinoma | MNDR-E-MI-33403 |
| MNDR | hsa-miR-26b-5p | Ovarian carcinoma | MNDR-E-MI-33404 |
| MNDR | hsa-miR-26b-5p | Carcinoma renal cell | MNDR-E-MI-33405 |
| MNDR | hsa-miR-26b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-33406 |
| MNDR | hsa-miR-26b-5p | Renal clear cell carcinoma | MNDR-E-MI-33407 |
| MNDR | hsa-miR-26b-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-33408 |
| MNDR | hsa-miR-26b-5p | Cholangiocarcinoma | MNDR-E-MI-33409 |
| MNDR | hsa-miR-26b-5p | Lung small cell carcinoma | MNDR-E-MI-33410 |
| MNDR | hsa-miR-26b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-33411 |
| MNDR | hsa-miR-26b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-33412 |
| MNDR | hsa-miR-26b-5p | Acute t cell leukemia | MNDR-E-MI-33413 |
| MNDR | hsa-miR-26b-5p | Acute heart failure | MNDR-E-MI-33414 |
| MNDR | hsa-miR-26b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-33415 |
| MNDR | hsa-miR-26b-5p | Early hepatocellular carcinoma | MNDR-E-MI-33416 |
| MNDR | hsa-miR-26b-5p | B-cell lymphoma | MNDR-E-MI-33417 |
| MNDR | hsa-miR-26b-5p | Rheumatoid arthritis | MNDR-E-MI-33418 |
| MNDR | hsa-miR-26b-5p | T-cell leukemia | MNDR-E-MI-33419 |
| MNDR | hsa-miR-26b-5p | Neuroblastoma | MNDR-E-MI-33420 |
| MNDR | hsa-miR-26b-5p | Barrett's adenocarcinoma | MNDR-E-MI-33421 |
| MNDR | hsa-miR-26b-5p | Osteoarthritis | MNDR-E-MI-33422 |
| MNDR | hsa-miR-26b-5p | Hodgkin lymphoma | MNDR-E-MI-33423 |
| MNDR | hsa-miR-26b-5p | Ulcerative colitis | MNDR-E-MI-33424 |
| MNDR | hsa-miR-26b-5p | Burkitt lymphoma | MNDR-E-MI-33425 |
| MNDR | hsa-miR-26b-5p | Dementia vascular | MNDR-E-MI-33426 |
| MNDR | hsa-miR-26b-5p | Psoriasis | MNDR-E-MI-33427 |
| MNDR | hsa-miR-26b-5p | Acute myelocytic leukemia | MNDR-E-MI-33428 |
| MNDR | hsa-miR-26b-5p | Colorectal cancer | MNDR-E-MI-33429 |
| MNDR | hsa-miR-26b-5p | Nasopharynx carcinoma | MNDR-E-MI-33430 |
| MNDR | hsa-miR-26b-5p | Multiple myeloma | MNDR-E-MI-33431 |
| MNDR | hsa-miR-26b-5p | Acute lymphocytic leukemia | MNDR-E-MI-33432 |
| MNDR | hsa-miR-26b-5p | Ovarian epithelial cancer | MNDR-E-MI-33433 |
| MNDR | hsa-miR-26b-5p | Cardiomegaly | MNDR-E-MI-33434 |
| MNDR | hsa-miR-26b-5p | Nasopharyngeal cancer | MNDR-E-MI-33435 |
| MNDR | hsa-miR-26b-5p | Stroke lacunar | MNDR-E-MI-33436 |
| MNDR | hsa-miR-26b-5p | Barrett's carcinogenesis | MNDR-E-MI-33437 |
| MNDR | hsa-miR-26b-5p | Breast cancer her3+ negative | MNDR-E-MI-33438 |
| MNDR | hsa-miR-26b-5p | High grade dysplastic nodule | MNDR-E-MI-33439 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022108 |
TOP